Aurinia Pharmaceuticals (AUPH) Asset Writedowns and Impairment (2021 - 2022)
Aurinia Pharmaceuticals' (AUPH) quarterly Asset Writedowns and Impairment came in at $1.2 million in Q4 2022, up 382.45% YoY from $245000.0 in Q4 2021, and up 382.45% on a QoQ basis from $245000.0 in Q4 2021.
Powered by 
Analysis
Aurinia Pharmaceuticals (AUPH) Asset Writedowns and Impairment (2021 - 2022) Analysis & Trends
Aurinia Pharmaceuticals (AUPH) has 2 years of Asset Writedowns and Impairment data on file, last reported at $1.2 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Aurinia Pharmaceuticals | 2.10 Bn | 1.66 Bn | 76.67 Mn |